Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep744 | Adrenal and Cardiovascular Endocrinology | ECE2024

Unlocking the metabolic mysteries: exploring metabolic syndrome in primary aldosteronism

Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Maalej Souhir , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary aldosteronism (PA) is associated with increased prevalence of metabolic disorders such as impaired glucose and lipid metabolism and insulin resistance. Individuals with PA have an increased risk of cardiovascular events. The aim of this study is to determine the characteristics of metabolic syndrome (MS) in patients with PA.Patients and methods: Retrospective study concerning 40 patients with PA over the period of 10 years from Janu...

ea0099ep299 | Adrenal and Cardiovascular Endocrinology | ECE2024

Prevalence and significance of hypokalemia in primary aldosteronism: a retrospective study

Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Maalej Souhir , Feki Wiem , Mnif Zeinab , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary hyperaldosteronism (PA) is the autonomous production of aldosterone by a disease primarily affecting the glomerular zone of the adrenal gland. It is one of the most frequent causes of secondary hypertension. The diagnosis should be suspected in the presence of the classic clinico-biological triad in patients presenting with hypertension, low plasma renin activity (PRA), with or without hypokalemia.Patients and Methods: Retrospective...

ea0099ep300 | Adrenal and Cardiovascular Endocrinology | ECE2024

Primary aldosteronism: insights from a single center cohort

Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Maalej Souhir , Feki Wiem , Mnif Zeinab , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary aldosteronism (PA) is commonly identified as the main cause of secondary hypertension. It is becoming increasingly wide-spread, affecting between 1 and 30% of people suffering from hypertension. We aim to describe the epidemiological, clinical and paraclinical characteristics of PA and to analyse its therapeutic and evolutionary aspects.Patients and methods: Retrospective and descriptive study concerning 40 patients with PA, collect...

ea0099ep920 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenal lesions do matter in the course of primary aldosteronism: a comparative analysis of Conn’s adenoma vs bilateral adrenal hyperplasia

Soomauroo Siddiqa , Hadjkacem Faten , Ridwaan Auckburally Ahmad , Missaoui Abdelmuhaymen , Maalej Souhir , Feki Wiem , Mnif Zeinab , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary aldosteronism (PA) is commonly identified as the main cause of secondary hypertension. It is becoming increasingly wide-spread, affecting between 1 and 30% of people suffering from hypertension. We aim to determine the different characteristics between aldosterone-producing adenoma (APA) and bilateral adrenal hyperplasia (BAH).Patients and methods: Retrospective descriptive and analytical study concerning 40 patients with PA, collec...

ea0099ep1100 | Adrenal and Cardiovascular Endocrinology | ECE2024

Cardiovascular and cerebrovascular burden associated with primary aldosteronism: a monocentric study

Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Maalej Souhir , Feki Wiem , Mnif Zeinab , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary aldosteronism (PA) is commonly identified as the main cause of secondary hypertension. It is becoming increasingly wide-spread, affecting between 1 and 30% of people suffering from hypertension. A prolonged exposure to high aldosterone concentrations has a deleterious effect on cardiovascular tissues and is associated with target organ damage, independently of blood pressure, so a higher risk of cardiovascular events has been reported in patients with pri...

ea0099ep1102 | Adrenal and Cardiovascular Endocrinology | ECE2024

Clinical features and complication profile of arterial hypertension in patients with primary aldosteronism

Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Maalej Souhir , Feki Wiem , Mnif Zeinab , Mnif Mouna , Abid Mohamed , Rekik Nabila

Introduction: Primary aldosteronism (PA) is frequently recognized as the main cause of secondary hypertension. Its prevalence is on the rise, impacting a range of 1 to 30% among individuals with hypertension.Patients and methods: Retrospective and descriptive study concerning 40 patients with PA, collected in the endocrinology department of the Hedi Chaker University Hospital of Sfax, over the period of 10 years from January 2010 to December 2022.<p ...

ea0099ep367 | Thyroid | ECE2024

A case of myasthenia gravis associated with hashimoto’s thyroiditis

Ben Salah Raida , Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Feki Wiem , Mnif Mouna , Marzouk Sameh , Abid Mohamed , Rekik Nabila , Bahloul Zouheir

Introduction: Myasthenia gravis (MG) is a chronic neuromuscular condition characterized by weakness in voluntary muscles. It is an autoimmune disorder. The emergence of the condition can be abrupt. As with any autoimmune disease (AID), it may be associated with other AIDs. We report a case of MG associated with Hashimoto’s thyroiditis (HT).Observation: The diagnosis of MG was established in a 58-year-old patient, based on the progressive onset of fa...

ea0099ep574 | Thyroid | ECE2024

Harmony and complexity: unveiling the multifaceted nature of multiple autoimmune syndrome

Ben Salah Raida , Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Feki Wiem , Mnif Mouna , Marzouk Sameh , Abid Mohamed , Rekik Nabila , Bahloul Zouheir

Introduction: Despite being organ-specific autoimmune diseases (AID), autoimmune thyroid diseases (AITD) may be associated with other AIDs either specific to other organs or systemic. These associations are not uncommon. They may be grouped in the form of an autoimmune polyendocrinopathy or multiple autoimmune syndrome (MAS). MAS is defined by the presence in the same person of at least three AIDs.Patients and Methods: It is a retrospective study over a ...

ea0099ep900 | Thyroid | ECE2024

Exploring the spectrum: complications of hyperthyroidism - insights from a series of 29 cases

Ben Salah Raida , Soomauroo Siddiqa , HadjKacem Faten , Ridwaan Auckburally Ahmad , Missaoui Abdelmuhaymen , Feki Wiem , Mnif Mouna , Marzouk Sameh , Abid Mohamed , Rekik Nabila , Bahloul Zouheir

Introduction: Overt hyperthyroidism is the result of excessive production of thyroid hormones. The diagnosis is made on the basis of clinical characteristics and the diagnosis of certainty is made by hormone assay, combining low TSH with increased thyroid hormones. If the hyperthyroidism is left untreated, symptoms progress and can lead to complications that may jeopardize life prognosis.Patients and Methods: A retrospective study involving 29 patients w...

ea0099ep1038 | Thyroid | ECE2024

Unmasking graves’ disease: navigating the complexities of diagnosis, treatment, and beyond

Ben Salah Raida , Soomauroo Siddiqa , Hadjkacem Faten , Missaoui Abdelmuhaymen , Ridwaan Auckburally Ahmad , Feki Wiem , Mnif Mouna , Marzouk Sameh , Abid Mohamed , Rekik Nabila , Bahloul Zouheir

Introduction: Graves’ disease (GD), an autoimmune disorder predominantly impacting the thyroid gland, can extend its effects to various organs, such as the eyes and skin. It stands as the leading cause of hyperthyroidism. It is defined by the pathognomonic combination of thyrotoxicosis, goitre and exophthalmos. The aim of this study was to identify the characteristics of GD.Patients and Methods: A retrospective study involving 31 patients with prima...